| FLYER
HIV/AIDS Drug Donations
and Price Reductions in Sub-Saharan Africa: A Public-Private Discussion
on Drug Registration, Diversion and Other Challenges
Tuesday, 15 April 2003
1:00 - 2:45 PM
United Nations Headquarters Conference Room 8
Roundtable Co-Chairpersons:
Christine Kapalata
H.E. Ousmane Moutari
Dr. Elaine M. Wolfson
Presented By:
Global Alliance for Women's Health (GAWH)
The Permanent Mission of the Republic of Angola to the United Nations
The Permanent Mission of the Republic of Benin to the United Nations
The Permanent Mission of Burkina Faso to the United Nations
The Permanent Mission of the Kingdom of Lesotho to the United Nations
The Permanent Mission of the Republic of Mali to the United Nations
The Permanent Mission of the Republic of Mauritius to the United Nations
The Permanent Mission of the Niger to the United Nations
The Permanent Mission of the United Republic of Tanzania to the United
Nations
This roundtable was made possible in part by
a grant from Merck & Co., Inc.
PARTICIPANTS & SPEAKERS
- Ms. Nicole Elisha,
Second Counsellor, the Permanent Mission of the Republic of Benin to
the United Nations
- Ms. Margarida Izata,
Minister Counsellor, the Permanent Mission of the Republic of Angola
to the United Nations
- Ms. Christine Kapalata,
Minister Counsellor, the Permanent Mission of the United Republic of
Tanzania to the United Nations
- Mr. Issa Konfourou,
Third Counsellor, the Permanent Mission of the Republic of Mali to the
United Nations
- H.E. Mr. Jagdish
Koonjul, Permanent Representative, the Permanent Mission of the
Republic of Mauritius to the United Nations
- Ms. Heather Lauver,
Senior Manager, International Philanthropy, Pfizer Inc
- Mr. Lefu Manyokole,
First Secretary, the Permanent Mission of the Kingdom of Lesotho to
the United Nations
- H.E. Mr. Ousmane
Moutari, Permanent Representative, the Permanent Mission of the
Niger to the United Nations
- Mr. François
Oubida, First Counsellor, the Permanent Mission of Burkina Faso
to the UN
- Jeffrey L. Sturchio,
Ph.D., Vice President, External Affairs, Merck & Co., Inc.
- Mr. Mark Speaker,
Vice President, International Government Affairs, Bristol-Myers Squibb
- Elaine M. Wolfson,
Ph.D. President, the Global Alliance for Women’s Health
|
|